Abstract

In the UK, around 0.5–1% of the population have epilepsy,1 and seizures remain uncontrolled in up to 50% of all people with the condition,2 which can have a significant impact on work, family and social life.2 Vagus nerve stimulation is now being used in both adults and children for epilepsy that is refractory to medical treatment.3–7 Worldwide, over 52,000 patients have been treated with such a device. Here we examine the place of vagus nerve stimulation therapy in the management of people with epilepsy.